REG - Iconic Labs PLC - Subscription of convertible notes

Iconic LabsAnnouncement

01/11/2022 17:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221101:nRSA9763Ea&default-theme=true

RNS Number : 9763E  Iconic Labs PLC  01 November 2022

1 November 2022

 

Iconic Labs Plc ("Iconic") In Administration

 

EHGOSF Subscribes to a £ 150,000 Second Tranche Under £ 3 Million Financing
Facility

 

Iconic announces that European High Growth Opportunities Securitization Fund
("EHGOSF") has subscribed to a £150,000 second tranche of convertible notes
under the £3 million financing facility that was entered into on 28 September
2022.

 

In exchange, Iconic will issue 150 convertible notes to EHGOSF along with
468,750,000 warrants with an exercise price of £ 0.00016.

 

The funds under this second tranche shall be used to meet Iconic's obligations
to critical and preferential creditors under the CVA and for operational
purposes as Iconic seeks to get its trading suspension lifted as soon as
possible.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEEAKFFELPAFFA